YOUR BUSINESS AUTHORITY
Springfield, MO
A U.S. trial of the Oxford-AstraZeneca COVID-19 vaccine confirmed its safety and effectiveness.
The trial found the vaccine was 79% effective at stopping symptomatic COVID disease and 100% effective at preventing people from becoming seriously ill from the virus.
BBC News reports the trial could clear the vaccine for use in the United States within a couple months.
Read more from BBC News.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects